Recombination low-dosage human alpha-2b(IFN-alpha-2b) interferon lozenge and preparing method thereof
An interferon, low-dose technology, applied in the field of medical and bioengineering, can solve the problems of small number of subtypes and unsatisfactory disease curative effect, and achieve the effect of obvious curative effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0031] A low-dose recombinant human α-2b (IFN-α-2b) interferon buccal tablet of the present invention, its formula is:
[0032] Low dose recombinant human α-2b (IFN-α-2b) interferon 100IU
[0033] Trehalose Powder 6%
[0034] Maltose powder 5%
[0035] Powdered sugar 55%
[0036] Starch 31%
[0037] Gelatin powder 2%
[0038] Magnesium Stearate 1%
Embodiment 2
[0040] A low-dose recombinant human α-2b (IFN-α-2b) interferon buccal tablet of the present invention, its formula is:
[0041] Low dose recombinant human α-2b (IFN-α-2b) interferon 300IU
[0042] Trehalose Powder 8%
[0043] Maltose Powder 6%
[0044] Powdered sugar 48%
[0045]Starch 35%
[0046] Gelatin powder 2%
[0047] Magnesium Stearate 1%
Embodiment 3
[0049] A low-dose recombinant human α-2b (IFN-α-2b) interferon buccal tablet of the present invention, its formula is:
[0050] Low dose recombinant human α-2b (IFN-α-2b) interferon 1000IU
[0051] Trehalose Powder 8%
[0052] Maltose Powder 8%
[0053] Powdered sugar 46%
[0054] Starch 35%
[0055] Gelatin powder 2%
[0056] Magnesium Stearate 1%
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap